Strep A Extraction Reagent (Bottle)

SECTION 2: Hazards identification

29 CFR 1910.1200) Regulatory status This preparation is classified as hazardous under U.S. OSHA 29 CFR 1910.1200. This medical diagnostic kit is controlled under the Canadian Food and Drugs Act and is exempt from classification, labeling and MSDS requirements under the Canadian Hazardous Products Act and Controlled Products Regulations.

Precautionary statements

WARNING! The chemical, physical and toxicological properties of this preparation have not been thoroughly characterized. Toxic by ingestion. Avoid contact with eyes and skin. Do not ingest or inhale. Preparation appearance: clear, pink liquid.

Potential health effects

Inhalation No data available. Substantial aerosol inhalation may result in symptoms similar to those specified for ingestion. Eyes No data available. Eye exposure may cause severe irritation, redness, watering, swelling and burning. Skin No data available. Skin contact with sufficient chemical absorption may result in symptoms similar to those specified for ingestion. Ingestion Ingestion of sodium nitrite may cause gastric irritation, nausea, vomiting and abdominal pain. Significant exposure may result in a drop in blood pressure, headache, dizziness, rapid pulse and visual problems. Skin may be flushed and sweaty and then become cold. Skin and lips may turn blue.

Potential chronic health

Chronic exposure to nitrites may cause headaches, visual problems and decreased blood pressure. Target organs Sodium nitrite: Cardiovascular and central nervous systems.

Environmental effects

See Section 12.